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ABSTRACT
Background The objective of this study was to
compare the costs and outcomes of two sexually
transmitted infection (STI) screening interventions
targeted at men in football club settings in England,
including screening promoted by team captains.
Methods A comparison of costs and outcomes was
undertaken alongside a pilot cluster randomised control
trial involving three trial arms: (1) captain-led and poster
STI screening promotion; (2) sexual health advisor-led
and poster STI screening promotion and (3) poster-only
STI screening promotion (control/comparator). For all
study arms, resource use and cost data were collected
prospectively.
Results There was considerable variation in uptake
rates between clubs, but results were broadly
comparable across study arms with 50% of men
accepting the screening offer in the captain-led arm,
67% in the sexual health advisor-led arm and 61% in
the poster-only control arm. The overall costs associated
with the intervention arms were similar. The average
cost per player tested was comparable, with the average
cost per player tested for the captain-led promotion
estimated to be £88.99 compared with £88.33 for the
sexual health advisor-led promotion and £81.87 for the
poster-only (control) arm.
Conclusions Costs and outcomes were similar across
intervention arms. The target sample size was not
achieved, and we found a greater than anticipated
variability between clubs in the acceptability of
screening, which limited our ability to estimate
acceptability for intervention arms. Further evidence is
needed about the public health beneﬁts associated with
screening interventions in non-clinical settings so that
their cost-effectiveness can be fully evaluated.
INTRODUCTION
Young people have the highest risk for sexually
transmitted infections (STIs) in the UK, and
attempts to engage young men in effective screen-
ing have proven to be particularly challenging.
Public Health England estimated that 16% of
young men aged 15–24 years were screened for
chlamydia during 2012 compared with 35% of
young women (assuming one test per person).1
A range of strategies have been proposed to
increase screening participation among men,
including outreach in non-clinical settings such as
sports venues.2 Recent research has suggested that
people without a healthcare background can suc-
cessfully promote certain health behaviours among
their peers.3 Among young men in England, foot-
ball has the highest levels of participation for a
team sport.4 The SPORTSMART pilot trial was
designed to develop and evaluate the feasibility and
acceptability of two replicable models for promot-
ing STI screening in football clubs (speciﬁcally,
Chlamydia trachomatis and Neisseria gonorrhoeae
screening), including screening promoted by team
captains.
The success of any new intervention in increasing
screening uptake needs to be balanced against the
resources required to achieve the desired outcome,
and additional costs must be evaluated in terms of
any additional beneﬁts that can be attributed to
them. The objectives of this economic analysis
were to obtain cost and outcome data for the alter-
native screening interventions developed by the
SPORTSMART pilot trial and to use these data in
a preliminary economic evaluation.
METHODS
Pilot trial
The methods and results of the pilot trial are
reported in detail elsewhere.5 In brief, a cluster ran-
domised control trial (RCT) design was used
involving the allocation of clubs, each with two
teams, to one of three trial arms: (1) captain-led
and poster STI screening promotion arm; (2)
sexual health advisor-led and poster STI screening
promotion arm and (3) poster-only STI screening
promotion control/comparator arm. The partici-
pants were men aged 18 years and over within six
amateur football clubs in London. Eligible football
clubs were grouped by similar characteristics into
three pairs, and then each of the pairs was rando-
mised to a study arm.
The interventions were delivered during the pre-
match team brieﬁng. For the captain-led promotion,
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the captain delivered a one-time standardised promotion talk of
<5 min duration, handed each player a specially designed
football-themed sample collection kit and answered any ques-
tions from players. In the sexual health advisor-led arm, the stan-
dardised promotion talk was delivered by a sexual health advisor
from the study clinic. In the poster-only arm, specially designed
posters were displayed and kits were made readily available, but
no verbal information was given. If men chose to participate,
they completed a sample collection kit and placed the completed
kit in a secure collection box at the club within an hour after the
match ended or they had the option of participating at a later
date and posting their sample back to clinic in a discrete postage-
paid envelope. Provision of test results and appropriate clinical
follow-up was undertaken by the clinical team in the study clinic
(off-site), according to routine clinical practice. This included
notiﬁcation of provision of test results via a text message (SMS)
by clinic staff.
The primary outcome was the proportion of eligible men
accepting the screening offer. The target was to achieve a
sample size of 200 men as this would allow the overall accept-
ance rate to be estimated within 7% if the rate was 50% (ie, a
95% CI 43% to 57%) and within 5% if the rate was higher or
lower, assuming minimal variability between clubs.
Economic analysis: overview
For all arms of the trial, resource use data were collected pro-
spectively and unit costs were applied. There were several ele-
ments that were common to all of the intervention arms; these
related to the recruitment and brieﬁng of the clubs, the materi-
als used within the interventions, and the collection and pro-
cessing of completed samples. The time taken to recruit, brief
and prepare the clubs for the screening intervention was
recorded and stafﬁng costs estimated using the Unit Costs of
Health and Social Care 2013.6 Costs associated with travel to
the clubs to prepare for the intervention were also included.
Specially designed posters, football-themed sample kit packs
and themed collection containers were used at all locations to
promote screening and provide the equipment necessary for
participation. We assumed that all these elements were an essen-
tial part of the intervention and included their costs in our esti-
mates. We assumed that designs and logos could be reused over
a period of 3 years until they became outdated, and thus annui-
tised all design and editing costs for 3 years at an interest rate of
3%.7 We assumed an even number of test kits across interven-
tion arms as data recorded in the trial demonstrated that similar
quantities of testing materials were used across arms, as unused
items were reused in other clubs. Transport costs associated with
returning the completed player samples to the study clinic
(off-site) were also included. Although players were given the
option to return their samples by post, only one sample was
returned by this method, and for the base case, we assumed that
the secure collection box would be the only method of speci-
men return provided.
Additional facilities were required for storage of the samples
before they were sent to the laboratory for processing. We
assumed that such additional storage would be needed if the
intervention were rolled out and that these facilities could be
reused over a period of 3 years; we included annuitised costs
accordingly. Costs associated with processing samples were esti-
mated using the cross charge between the processing laboratory
and the study clinic. Staff time associated with patient adminis-
tration at the clinic was recorded and costs estimated. We also
included costs associated with notifying players about their
results and any further costs associated with patient consultation
and treatment. For all trial arms, data were collected on direct
health service costs and some of the private costs incurred by
the players and captains. The main analysis was conducted from
the perspective of the health service (National Health Service).
Resource use and cost deﬁnition
Captain- and poster-promoted screening
The estimated cost of the captain-led screening intervention
included costs for a member of staff (a healthcare assistant)
from the clinic undertaking the sample processing and notiﬁca-
tion to be on site before and after the intervention to deliver
and prepare all the materials and to facilitate the safe return of
the completed samples to the clinic, based on recorded practice
within the pilot trial and clinical governance requirements. For
the base case, it was assumed that the time taken by the team
captain to prepare for and deliver the intervention was forgone
leisure time and would not impact on health service costs.
However, the effect of including these costs or some kind of
ﬁnancial incentive for the captain was analysed as part of the
sensitivity analysis.
Sexual health advisor- and poster-promoted screening
The estimated costs for the health advisor-promoted interven-
tion included costs for a sexual health advisor to lead the
screening promotion. We assumed that the health advisor would
also take the materials to the club, prepare the promotion and
ensure the safe return of completed specimen samples to the
clinic, in accordance with trial processes and clinical governance
requirements and hence included time and travel costs in our
estimates.
Poster-promoted screening only (control)
As for the captain-led arm, we assumed that a member of staff
(a healthcare assistant) from the clinic undertaking the testing
and notiﬁcation would need to be on site before and after the
promotion and included costs accordingly.
Analysis
We conducted a cost-consequences analysis that involves com-
paring the costs and outcomes associated with all three interven-
tions separately.8 This kind of analysis is more appropriate than
a full economic evaluation because the current study is a pilot
only and a full RCT has not been carried out.
We assessed costs and outcomes in a disaggregated manner
for each intervention arm to establish whether any showed clear
dominance. Dominance is judged to have occurred when one
intervention costs less but is more effective, in terms of the
outcome achieved, compared with a different intervention.
Conversely, an intervention is dominated if it costs more but is
less effective than the comparator. We examined costs and con-
sequences for all three arms. The main analysis is based on the
outcome of whether the player accepted the offer of screening.
All cost data reported are presented in British pounds in 2012/
2013 prices.
A series of one-way deterministic sensitivity analyses were
carried out. Uncertainties around all key cost and outcome para-
meters were analysed, and plausible ranges were speciﬁed using
information from the trial and from the literature. These ana-
lyses included (a) reducing club recruitment time substantially to
4 h per club by developing a higher-level agreement with the
Football Association; (b) including an incentive of £1000 for
each club to help maximise participation (to reﬂect practice
within the study); (c) including broader societal costs associated
with captain participation in screening, with the assumption
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that the time taken to participate in the intervention was
forgone leisure time, valued at 40% of the median hourly
wage;9 10 (d) reducing intervention costs for the poster-only
control arm to analyse the impacts of different stafﬁng arrange-
ments; (e) adjusting the cost of the test kit boxes to account for
the logo and design costs associated with unused boxes; (f )
increasing sample processing costs and (g) varying uptake levels
by study arm. Further sensitivity analyses were carried out but
are not reported.
RESULTS
Across all three of the trial arms, 153 men received the interven-
tion and 90 of them accepted the screening offer (59%, 95% CI
35% to 79%, using a robust SE to acknowledge the clustering of
participants by club). There was considerable variation in the
uptake rates between individual clubs, but results were broadly
comparable across study arms (table 1). For the captain-led arm,
56 men received the promotion and 28 accepted (50%). For the
health advisor-led arm, 46 men attended the promotion and 31
accepted (67%). For the poster-only control arm, 51 men received
the promotion and 31 accepted (61%). There were no positive test
results for chlamydia or gonorrhoea in any of the study arms.
Full costs for each of the intervention arms are shown in
table 2, and further details are included in online supplementary
appendix 1. The results of the pilot trial suggested that total costs
were similar across all of the intervention arms, with the total
costs of the captain-promoted screening intervention estimated
to be £2491.61 compared with £2738.09 for the health
advisor-led arm and £2538.09 for the poster-only arm. Overall
costs were similar because the highest proportion of costs related
to ﬁxed costs, such as staff time for recruiting and brieﬁng the
clubs and the equipment required for delivering the promotion.
For all three intervention arms, costs were compared with the
main outcome of screening uptake (table 3). The average cost
per player tested was comparable across the trial arms using the
base case results, with the average cost per player tested for the
captain-led promotion estimated to be £88.99 compared with
£88.33 for the sexual health advisor-led screening promotion
and £81.87 for the poster-only (control) arm.
Sensitivity analysis
As demonstrated in table 4, the results were as follows: (a)
decreasing the time needed for club recruitment reduced overall
costs, with the cost per player screened ranging from £60.14 to
£66.59; (b) including an incentive in our analysis increased
overall costs for all trial arms; (c) including costs for team cap-
tains to deliver the promotion made the captain-led arm slightly
more expensive, however, as process evaluation revealed that
team captains had also informally promoted the screening inter-
vention in other trial arms including these costs for the
captain-led arm alone may not be justiﬁed; (d) reducing inter-
vention costs for the poster control arm led to a reduction in
overall costs for this arm; (e) increasing the costs associated with
the test kit boxes (to adjust for costs associated with unused
boxes) increased total costs for all intervention arms with esti-
mates per player screened ranging from £84.26 to £91.63; (f )
increasing sample processing costs increased costs for all trial
arms and (g) varying uptake levels had an effect on the result,
emphasising the importance of an accurate estimate of
effectiveness.
DISCUSSION
This was an exploratory economic evaluation comparing the
costs and outcomes of alternative models for promoting screen-
ing among young men. The results as a whole suggest that all
these methods of screening promotion are acceptable to players
within amateur football clubs, with 153 men receiving the inter-
vention and 90 accepting the offer of screening (59%, 95% CI
35% to 79%). The overall costs associated with the intervention
arms were similar. The outcome of average cost per player
screened was comparable across all arms, with the average cost
per player tested for the captain-led promotion estimated to be
£88.99 compared with £88.33 for the sexual health advisor-led
screening promotion and £81.87 for the poster-only (control)
arm. This outcome is affected by the estimate of the number of
players accepting screening, and as our ability to estimate uptake
for any single intervention arm is limited, drawing conclusions
about the relative costs and consequences of the interventions is
not justiﬁed. No intervention model can be judged to be domin-
ant, and the average cost per player tested can be seen as com-
parable across all of the study arms.
It might have been expected that the costs associated with the
poster-only control and captain-led arms would be lower than
for the health advisor-led arm. However, costs were found to be
similar due to the need for a member of clinic staff to be on site
and ensure the return of samples to clinic, to meet clinical
guidelines. In the event of a rollout of the trial, a satisfactory
alternative to this arrangement might be found.
This study has several limitations. It was difﬁcult to draw ﬁrm
conclusions about the relative cost-effectiveness of the interven-
tions in the trial as screening uptake could not be estimated
with precision for any single intervention arm. Two clubs were
randomised to each intervention arm; however, we found a
greater than anticipated variability between clubs in the accept-
ability of screening, which limited our ability to estimate accept-
ability for intervention arms. In addition, the overall target
sample size was not achieved due to difﬁculties in recruitment
linked to poor weather and rescheduled matches. We did not
capture additional downstream testing that may have occurred
as a result of the intervention, and so uptake of STI testing
might have been underestimated. As the trial did not identify
any positive cases of chlamydia or gonorrhoea, it was not pos-
sible to estimate a cost per case diagnosed.
Within the economic analysis, some assumptions were made
about how the interventions would operate if they were rolled
out, and although these were examined within a sensitivity ana-
lysis, they would need to be tested at a larger scale. A one-way
Table 1 Screening uptake for clubs within the study arms
Study arm Club
Players in
changing
room
Completed
kits
returned
Percentage
of return
Captain-led A 26 10 38.5
Captain-led B 30 18 60.0
56 28 50.0
Health advisor-led A 24 10 41.7
Health advisor-led B 22 21 95.5
46 31 67.4
Poster-only
(control)
A 24 20 83.3
Poster-only
(control)
B 27 11 40.7
51 31 60.8
Total All 153 90 58.8
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deterministic sensitivity analysis was carried out since this is a
preliminary economic analysis alongside a pilot trial and a full
probabilistic sensitivity analysis would not be appropriate
because of the small sample size and the heterogeneity of
uptake rates at club level. Further uncertainties around cost and
outcomes parameters would need to be analysed if a full RCT
was conducted. Finally, it was intended that players in the
control arm would be uninﬂuenced by team captains, but their
enthusiasm for the intervention meant that this was not pos-
sible, and captains encouraged players to participate in screening
via regular team information emails.
The strength of this study is that detailed data on costs and
resource use were collected which can inform similar interven-
tions in this area and enable comparisons with other research
ﬁndings. In addition, data were collected on the number of
players who attended the screening promotion events, and thus
it is possible to estimate the level of uptake of screening. Often
with such health promotion interventions, the number of
people exposed to a particular intervention is unknown.
Very little information exists about the cost-effectiveness of
screening programmes in non-clinical settings. A recent system-
atic review of studies concerned with chlamydia and gonorrhoea
screening outreach programmes only identiﬁed three with infor-
mation on costs.11 Buhrer-Skinner et al12 calculated a cost per
test carried out for outreach clinics in Australia but did not
include staff time, transport and setup costs. Morris et al calcu-
lated the costs associated with two Californian youth pro-
grammes but did not include additional time associated with
volunteer input.13 Detailed costings were also provided by a
study evaluating the cost-effectiveness of a multifaceted commu-
nity intervention to increase screening in Stockholm.14
However, due to the nature of the intervention, which involved
a large-scale publicity campaign and expanded access to testing
facilities, it is difﬁcult to compare these results with the
SPORTSMART study. The ﬁndings of a costing study of chla-
mydia screening within primary care suggest that the costs per
case screened for the SPORTSMART study are higher than
would usually be expected in a UK primary care setting.15
However, the additional public health beneﬁts associated with
outreach activities would also need to be taken into account and
achieving adequate coverage of screening in primary care, espe-
cially in men, is challenging.
Conclusions
This preliminary economic evaluation has shown that similar costs
and outcomes were demonstrated across all three study arms. The
fact that the control arm was unintentionally ‘enhanced’ by team
captains suggests that they can have an important inﬂuence on
screening uptake, irrespective of whether they take on a formal
role in promoting the intervention and the potential costs
Table 2 Health service costs for intervention arms (two clubs per arm)
Resources used Cost item Unit cost £* N Total cost £*
Intervention costs
Recruitment of club Per club 516.88 2 1033.75
Poster pack† Per pack 53.92 2 107.85
Test kit† Per player 5.66 46 260.36
Promotion Per club Captain-led: 125.00 2 Captain-led: 250.00
Health advisor-led: 225.00 Health advisor-led: 450.00
Poster-only: 125.00 Poster-only: 250.00
Specimen collection box† Per club 55.62 2 111.25
Transport of specimen collection box Per club 135.64 2 271.28
Processing costs
Additional storage facilities‡ Per club 11.63 2 23.26
Sample processing Per player tested 10.79 Captain-led: 28 302.12
Health advisor-led: 31 334.49
Poster-only: 31 334.49
Patient admin and notification of results Per player tested 4.71 Captain-led: 28 131.74
Health advisor-led: 31 145.86
Poster-only: 31 145.86
Total cost Captain-led: 2491.61
Health advisor-led: 2738.09
Poster-only: 2538.09
*Costs are UK£ (2012/2013).
†Includes costs for the first year of the design elements of the posters, test kit box, pens and specimen collection boxes, annuitised at 3% for 3 years.
‡Includes costs for the first year of the storage facilities, annuitised at 3% for 3 years.
Table 3 Comparison of costs and outcomes for the intervention arms
Intervention arm* Total cost £†
Number of
players tested
Per cent accepting
screening offer
Average cost per
player screened £†
Captain-led 2491.61 28 50 88.99
Health advisor-led 2738.09 31 67 88.33
Poster-only (control) 2538.09 31 61 81.87
*Includes costs and outcomes for both clubs in each trial arm.†Costs are UK£ (2012/2013).
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associated with their informal and formal input need to be care-
fully considered. Further research is needed to explore the public
health beneﬁts associated with screening interventions in non-
clinical settings so that their cost-effectiveness can be fully evalu-
ated. This would allow the potentially higher costs associated with
such ‘outreach’ activities to be weighed against their wider health
beneﬁts so that policymakers can be fully informed about which
approaches offer the best value for money.
Key messages
▸ Although acceptance rates were highly variable between clubs,
levels of uptake were broadly comparable across all study arms.
▸ The overall costs associated with the intervention arms were
similar.
▸ No intervention model was judged to be dominant, and the
average cost per player tested was comparable across all of
the study arms.
▸ Further research is needed to investigate the public health
beneﬁts associated with screening interventions in
non-clinical settings so that their cost-effectiveness can be
fully evaluated.
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